1. Home
  2. SMID vs TLSI Comparison

SMID vs TLSI Comparison

Compare SMID & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$36.00

Market Cap

206.7M

Sector

Industrials

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$7.45

Market Cap

244.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMID
TLSI
Founded
1960
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.7M
244.3M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
SMID
TLSI
Price
$36.00
$7.45
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$11.50
AVG Volume (30 Days)
8.7K
258.1K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
81.92
N/A
EPS
2.22
N/A
Revenue
$88,866,000.00
$40,207,000.00
Revenue This Year
N/A
$55.06
Revenue Next Year
N/A
$46.04
P/E Ratio
$15.89
N/A
Revenue Growth
16.37
49.52
52 Week Low
$25.13
$3.42
52 Week High
$48.41
$7.70

Technical Indicators

Market Signals
Indicator
SMID
TLSI
Relative Strength Index (RSI) 54.49 69.62
Support Level $33.33 $6.96
Resistance Level $36.68 $7.53
Average True Range (ATR) 1.67 0.51
MACD 0.41 -0.00
Stochastic Oscillator 82.00 84.86

Price Performance

Historical Comparison
SMID
TLSI

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Share on Social Networks: